Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma-Reference-Cited by-同舟云学术

Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma

Published:2017-06-15 Issue:12 Volume:2 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Casuscelli Jozefina,Weinhold Nils,Gundem Gunes,Wang Lu,Zabor Emily C.,Drill Esther,Wang Patricia I.,Nanjangud Gouri J.,Redzematovic Almedina,Nargund Amrita M.,Manley Brandon J.,Arcila Maria E.,Donin Nicholas M.,Cheville John C.,Thompson R. Houston,Pantuck Allan J.,Russo Paul,Cheng Emily H.,Lee William^ORCID,Tickoo Satish K.,Ostrovnaya Irina,Creighton Chad J.,Papaemmanuil Elli,Seshan Venkatraman E.,Hakimi A. Ari,Hsieh James J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/92688/files/pdf

Reference55 articles.

1. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

2. Comprehensive molecular characterization of clear cell renal cell carcinoma

3. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

4. The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians;Journal of Urologic Oncology;2024-07-31

2. The Role of the PAX Genes in Renal Cell Carcinoma;International Journal of Molecular Sciences;2024-06-19

3. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset;Modern Pathology;2024-05

4. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma;Modern Pathology;2024-05

5. Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma;JCI Insight;2024-04-18